journal article·2025-10Open access

US-triggered on-demand NO-releasing biomimetic nanoparticle to Remodel endothelial microenvironment for enhancing atherosclerosis-specific gas therapy

Lingling Xu, Daifang Zhang, Li Song, Yifei Wu, Longqi Jiang, Zhenyu Liu, Xin Qian, Jun Zhou, Yong Liu, Ya Wu

Abstract

Atherosclerosis (AS) is a chronic inflammatory disease driven by endothelial dysfunction, vascular smooth muscle cell proliferation, and insufficient resolution of inflammation. Nitric oxide (NO) plays a crucial role in vascular homeostasis by promoting endothelial cell proliferation, maintaining endothelial integrity, suppressing smooth muscle cell hyperplasia, and exerting potent anti-inflammatory effects. However, clinical application of NO is hindered by its short half-life, lack of targeting, and uncontrolled release. Here, we developed the biomimetic nanoparticles (B-NPs@MM) for targeted and controllable NO delivery by encapsulating the ultrasound (US)-responsive NO donor BNN6 into poly(lactic-co-glycolic acid) (PLGA) nanospheres followed by coating with macrophage-derived membranes. These biomimetic particles mimic natural macrophages to actively target inflamed atherosclerotic plaques and evade immune clearance. Upon localized US exposure, the system triggers rapid and on-demand NO release at the lesion site with spatiotemporal precision. In vitro and in vivo evaluations demonstrate effective NO delivery, enhanced endothelial repair, reduced inflammation, and inhibition of neointimal hyperplasia. This work presents a smart, remotely controlled NO nanotherapy platform based on artificial immune cell design, offering a promising strategy for precision treatment of AS.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Anesthesia and Neurotoxicity Research · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (53)

Show source-provided references
1. Distinct inflammatory pathways shape atherosclerosis in different vascular beds10.1093/eurheartj/ehaf054 ↗
2. Chen · 2025 · vol. 8 · 754
3. Epidemiology of atherosclerosis and the potential to reduce the global burden of Atherothrombotic disease10.1161/CIRCRESAHA.115.307611 ↗
4. Management of patients with chronic coronary disease10.1001/jama.2024.9813 ↗
5. Treatment models of cardiac rehabilitation in patients with coronary heart disease and related factors affecting patient compliance10.31083/j.rcm.2019.01.53 ↗
6. Nanotechnology for cardiovascular diseases
7. Nitric oxide signaling in health and disease10.1016/j.cell.2022.06.010 ↗
8. Nitric oxide signalling in cardiovascular health and disease10.1038/nrcardio.2017.224 ↗
9. Nitric oxide signaling and regulation in the cardiovascular system: recent advances10.1124/pharmrev.124.001060 ↗
10. Erythropoietin and a nonerythropoietic peptide analog promote aortic endothelial cell repair under hypoxic conditions: role of nitric oxide10.2147/HP.S104377 ↗
11. Biocatalytic nitric oxide generating hydrogels with enhanced anti-inflammatory, cell migration, and angiogenic capabilities for wound healing applications10.1039/D3TB01943H ↗
12. Platelets and cardioprotection: the role of nitric oxide and carbon oxide10.3390/ijms24076107 ↗
13. Nitric oxide: physiological functions, delivery, and biomedical applications
14. Innovative nitric oxide-releasing nanomaterials: current progress, trends, challenges, and perspectives in cardiovascular therapies10.1016/j.niox.2025.03.004 ↗
15. Progress and promise of nitric oxide-releasing platforms
16. Delivery of nitric oxide in the cardiovascular system: implications for clinical Diagnosis and therapy10.3390/ijms222212166 ↗
17. Delivering nitric oxide with nanoparticles10.1016/j.jconrel.2015.02.007 ↗
18. An ultrasound-triggered nanoplatform for synergistic Sonodynamic-nitric oxide therapy10.1021/acsbiomaterials.2c01431 ↗
19. Ultrasound-driven nitric oxide generation for enhanced sonodynamic-photothermal therapy10.1021/acs.molpharmaceut.4c01401 ↗
20. MRI-guided and ultrasound-triggered release of NO by advanced nanomedicine10.1039/C7NR00231A ↗
21. A novel ultrasound-responsive biomimetic nanoparticle for targeted delivery and controlled release of nitric oxide to attenuate myocardial ischemia
22. A novel ultrasound-triggered cardiac patch for targeted nitric oxide delivery to promote angiogenesis and reduce inflammation for the treatment of myocardial infarction10.1016/j.cej.2025.164172 ↗
23. Mechanisms and treatment of atherosclerosis: focus on macrophages
24. Tuning macrophages for atherosclerosis treatment10.1093/rb/rbac103 ↗
25. Macrophage phenotype and function in different stages of atherosclerosis10.1161/CIRCRESAHA.115.306256 ↗
26. Macrophage mimetics to target atherosclerosis10.1038/s41569-020-0404-x ↗
27. Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect10.1186/s12951-022-01720-2 ↗
28. Macrophage membrane biomimetic drug delivery system: for inflammation targeted therapy10.1080/1061186X.2022.2071426 ↗
29. Xu · 2024 · vol. 34
30. Biomimetic neutrophil and macrophage dual membrane-coated nanoplatform with orchestrated tumor-microenvironment responsive capability promotes therapeutic efficacy against glioma10.1016/j.cej.2021.133848 ↗
31. Visualization of the ferroptosis in atherosclerotic plaques with nanoprobe engineered by macrophage cell membranes10.1021/acs.analchem.3c03999 ↗
32. Macrophage membrane enveloped on double-locked nanoplatform with right-side-out orientation to improving precise theranostic for atherosclerosis10.1016/j.jconrel.2025.02.034 ↗
33. Li · 2022 · vol. 11
34. A macrophage membrane-functionalized
35. Macrophage membrane-engineered biomimetic nanoplatform to potentiate STING pathway-mediated tumor immunotherapy
36. Macrophage membrane‒biomimetic nanoparticles target inflammatory microenvironment for epilepsy treatment10.7150/thno.99260 ↗
37. Engineered cell membrane coating technologies for Biomedical applications: from Nanoscale to Macroscale10.1021/acsnano.4c16280 ↗
38. The Macrophage 'Do not eat me' signal, CD47, is a clinically validated cancer immunotherapy target10.1093/annonc/mdz006 ↗
39. Atherosclerosis: recent developments10.1016/j.cell.2022.04.004 ↗
40. Theodorou
41. Disturbed flow impairs MerTK-mediated efferocytosis in aortic endothelial cells during atherosclerosis10.7150/thno.93036 ↗
42. Lazzarato · 2023 · vol. 28 · 5724
43. Tabish · 2024 · vol. 9 · 691
44. Nitric oxide-releasing Bioinspired Scaffold for Exquisite regeneration of Osteoporotic Bone via regulation of
45. S-nitrosocysteamine-functionalised porous graphene oxide nanosheets as nitric oxide delivery vehicles for cardiovascular applications10.1016/j.redox.2024.103144 ↗
46. Wei
47. Caligiuri · 2020 · 126 · 1178
48. Characterization of S100A4-induced inflammatory SMCs in vitro and role of S100A4-expressing medial SMCs during early stages of atherosclerosis in ApoE-/- mice10.1093/cvr/cvac066.203 ↗
49. A novel ultrasound-responsive biomimetic nanoparticle for targeted delivery and controlled release of nitric oxide to attenuate myocardial Ischemia Reperfusion injury10.1002/sstr.202300004 ↗
50. Thamphiwatana · 2017 · 114 · 11488
51. Engineered macrophage membrane-coated nanoparticles for hepatic Ischemia–Reperfusion
52. Fluorescent and colorimetric dual-readout sensor based on Griess assay for nitrite detection10.1016/j.saa.2019.117470 ↗
53. Rapid and dual-mode nitrite detection with improved sensitivity by nanointerface-regulated ultrafast Griess assay10.1016/j.aca.2024.343524 ↗